Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Basic) (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed EPS (Basic) for 15 consecutive years, with $0.05 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 44.44% to $0.05 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.23 through Dec 2025, up 130.0% year-over-year, with the annual reading at $0.22 for FY2025, 100.0% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.05 at Niagen Bioscience, down from $0.06 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.09 in Q4 2024, with the low at -$0.13 in Q3 2021.
  • Average EPS (Basic) over 5 years is -$0.02, with a median of -$0.01 recorded in 2022.
  • The sharpest move saw EPS (Basic) tumbled 85.71% in 2021, then surged 25231.33% in 2025.
  • Over 5 years, EPS (Basic) stood at -$0.07 in 2021, then soared by 71.43% to -$0.02 in 2022, then skyrocketed by 107.6% to $0.0 in 2023, then skyrocketed by 5819.87% to $0.09 in 2024, then tumbled by 44.44% to $0.05 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $0.05, $0.06, and $0.05 for Q4 2025, Q3 2025, and Q2 2025 respectively.